Filing Flows › Sotera Health (SHC) › Q3 2026 › vs Q2 2026
Sotera Health (SHC) Q3 2026 vs Q2 2026 (quarter over quarter)
Sotera Health's revenue rose $3.5M (+1%) from $321M in Q2 2026 to $325M in Q3 2026. The biggest changes: Nordion +$5.9M (+12%); Sterigenics −$2.3M (-1%); Nelson Labs −$98K (-0.2%). Gross margin 55.6% against 55.4% (+0.3 pts).
Sotera Health, Q3 2026: revenue $325M (+4% year over year), operating margin 25.8%, net earnings $58.4M, operating cash flow $111M. The chart draws each line against Q2 2026, the increases inside each band.
Margins
| Q3 2026 | Q2 2026 | Change | |
|---|---|---|---|
| Gross margin | 55.6% | 55.4% | +0.3 pts |
| Operating margin | 25.8% | 24.3% | +1.5 pts |
| Net margin | 18.0% | 16.7% | +1.3 pts |
| Free cash flow margin | 17.8% | 13.1% | +4.7 pts |
Every line
| Line | Q3 2026 | Q2 2026 | Change | % |
|---|---|---|---|---|
| Sterigenics | $209M | $212M | −$2.3M | -1% |
| Nelson Labs | $60.6M | $60.7M | −$98K | -0.2% |
| Nordion | $55.0M | $49.1M | $5.9M | +12% |
| Revenue | $325M | $321M | $3.5M | +1% |
| Gross profit | $181M | $178M | $2.8M | +2% |
| Cost of revenue | $144M | $143M | $685K | +0.5% |
| Operating profit | $83.7M | $78.1M | $5.7M | +7% |
| Operating expenses | $97.1M | $99.9M | −$2.9M | -3% |
| Pre-tax earnings | $83.7M | $78.1M | $5.7M | +7% |
| SG&A | $64.1M | $68.2M | −$4.0M | -6% |
| Other operating costs | $32.9M | $31.8M | $1.2M | +4% |
| Net earnings | $58.4M | $53.6M | $4.7M | +9% |
| Income tax | $25.3M | $24.4M | $933K | +4% |
| Depreciation & amortization | $32.5M | $33.4M | −$878K | -3% |
| Share-based compensation | $7.7M | $7.2M | $513K | +7% |
| Working capital & other | $11.9M | −$5.8M | $17.7M | — |
| Operating cash flow | $111M | $88.5M | $22.1M | +25% |
| Free cash flow (OCF − capex) | $57.7M | $42.0M | $15.7M | +37% |
| Capital expenditures | $52.8M | $46.4M | $6.4M | +14% |
Questions
How much did Sotera Health's revenue grow quarter over quarter in Q3 2026?
Sotera Health's revenue rose $3.5M (+1%) from $321M in Q2 2026 to $325M in Q3 2026.
What drove Sotera Health's revenue change in Q3 2026?
Nordion +$5.9M (+12%); Sterigenics −$2.3M (-1%); Nelson Labs −$98K (-0.2%).